The CALERIE trial

CALERIE is a two-year randomised trial of calorie restriction in healthy, non-obese people, and the study most often quoted as proof that eating less slows human aging. It did improve heart and metabolic markers and nudged one aging clock, but the clock result was small and found after the fact, people managed about half the restriction they were asked for, and the weight they lost included some lean mass, in proportion to the weight lost, and a little bone density.

Read CALERIE as evidence that moderate calorie restriction moves biomarkers in the right direction, not that it extends life. If you try restriction, protect muscle and bone with enough protein and resistance training, and aim to keep the weight off rather than cycling it.

What the trial did

CALERIE (Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy) randomised 220 healthy adults without obesity, aged 21 to 50, either to cut their calorie intake by 25% or to keep eating normally, for two years. Twice as many people were assigned to restriction as to the control group. In practice, participants achieved only about 12% restriction against the 25% target: roughly half of what was asked.^[1]

It was designed to measure restriction's effects on metabolism and body composition; the methylation-clock analysis was added later, using stored blood samples.

What it cost: lean mass, strength and bone

Restriction improved cardiometabolic markers, but not all of the weight that came off was fat. After two years the restricted group had lost about 7.6 kg, including about 2.0 kg of fat-free (lean) mass, roughly in proportion to the weight lost; the control group's lean mass barely changed.^[2]

Strength. Absolute leg strength fell, even though strength per kilogram of body weight rose.^[3]
Bone. Bone mineral density dropped modestly at the spine and hip, which the investigators flagged as a potential limitation of prolonged restriction.^[4]

These were young and middle-aged, healthy volunteers. The trial did not test older adults, in whom lean-mass and bone loss matter more.

The aging-clock result, and three reasons to hold it loosely

CALERIE slowed the DunedinPACE methylation clock, a DNA-methylation measure of the pace of aging, by roughly 2–3%: the restricted group accumulated biological age about 2–3% more slowly than controls. That is a real but small shift.^[5]

It was post hoc. The methylation analysis was done after the trial, not as its designed test.
The dose fell short. About 12% restriction, not 25%.
One clock moved, the others did not. There was no significant change on the other methylation clocks tested, including PhenoAge and GrimAge. Never quote it as "slowed aging clocks", plural.

It remains the cleanest human evidence that calorie restriction does something to the biology of aging, and it is a biomarker result, not a survival result.

Two later analyses

Organ-by-organ scores. Biological-age scores built from routine clinical biomarkers rather than methylation, in 185 of the participants, rose more slowly under restriction for metabolic, cardiovascular, immune and whole-body age, though not kidney age. Whole-body age ended about 1.3 years lower than in the normal-eating group after two years.^[6] These are surrogate measures, not health outcomes.
Weight regain undid the gains. The 20 participants who regained more than 5% of their starting weight in the second year lost the improvements in insulin and IGF-1 (insulin-like growth factor 1) signalling. That comparison grouped people by what their weight did rather than by randomised arm, so it shows an association, not proof.^[7]

What it doesn't show

CALERIE did not measure lifespan or death, and no trial of restriction in healthy, non-obese people has. Whether a few percent on one clock translates into longer or healthier life is unknown. In mice, a large 2024 study of 960 female mice found that the metabolic improvements restriction produced were not the things associated with living longer, and that the deepest restriction cost lean mass; the wider context is on deregulated nutrient sensing.

What to do

Don't treat CALERIE as proof that eating less makes you live longer. It shows biomarker shifts in healthy young and middle-aged adults.
If you restrict, defend muscle and bone: enough protein and regular resistance training.
Aim for weight you can keep. In the trial, people who regained the weight lost the insulin and IGF-1 gains (an association, not a randomised comparison).